These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 198822)

  • 1. Therapy of experimental herpes simplex keratitis in rabbits with 5-lodo-5'-amino-2',5'-dideoxyuridine (39882).
    Puliafito CA; Robinson NL; Albert DM; Pavan-Langston D; Lin TS; Ward DC; Prusoff WH
    Proc Soc Exp Biol Med; 1977 Oct; 156(1):92-6. PubMed ID: 198822
    [No Abstract]   [Full Text] [Related]  

  • 2. Adenine arabinoside effect on experimental idoxuridine-resistant herpes simplex infection.
    Nesburn AB; Robinson C; Dickinson R
    Invest Ophthalmol; 1974 Apr; 13(4):302-4. PubMed ID: 4362055
    [No Abstract]   [Full Text] [Related]  

  • 3. Light intensity on the photodynamic inactivation of herpes simplex keratitis.
    Stanley JA; Pinnolis M
    Am J Ophthalmol; 1976 Mar; 81(3):332-6. PubMed ID: 176890
    [No Abstract]   [Full Text] [Related]  

  • 4. Herpes simplex virus types 1 and 2: therapeutic response to antiviral drugs.
    North RD; Pavan-Langston D; Geary P
    Arch Ophthalmol; 1976 Jun; 94(6):1019-21. PubMed ID: 180942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acquired idoxuridine resistance of herpes simplex virus. Clinical data (author's transl)].
    Colin J; Chastel C
    Sem Hop; 1978 Oct 18-25; 54(33-36):1071-2. PubMed ID: 220719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acyclic antimetabolite therapy of experimental herpes simplex keratitis.
    Pavan-Langston D; Campbell R; Lass J
    Am J Ophthalmol; 1978 Nov; 86(5):618-23. PubMed ID: 213976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of various factors on the proliferation of herpes simplex virus. II. With regard to the problem of tolerance of the herpes simplex virus for IDU].
    Oshima K
    Nippon Ganka Gakkai Zasshi; 1967 Aug; 71(8):1211-6. PubMed ID: 4295686
    [No Abstract]   [Full Text] [Related]  

  • 8. Idoxuridine-liposome therapy for herpes simplex keratitis.
    Smolin G; Okumoto M; Feiler S; Condon D
    Am J Ophthalmol; 1981 Feb; 91(2):220-5. PubMed ID: 7468738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Idoxuridine-resistant ocular herpes].
    Colin J; Chastel C; Baikoff G; Renard G
    Bull Soc Ophtalmol Fr; 1979 Oct; 79(10):889-91. PubMed ID: 233306
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of trisodium phosphonoformate and idoxuridine on experimental herpes simplex keratitis in immunized and non-immunized rabbits.
    Alenius S; Laurent U; Oberg B
    Acta Ophthalmol (Copenh); 1980 Apr; 58(2):167-73. PubMed ID: 6249066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newer compounds in therapy of herpes simplex keratitis.
    Hyndiuk RA; Kaufman HE
    Arch Ophthalmol; 1967 Nov; 78(5):600-5. PubMed ID: 4293002
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of phosphonoacetic acid in the treatment of experimental herpes simplex keratitis.
    Gordon YJ; Lahav M; Photiou S; Becker Y
    Br J Ophthalmol; 1977 Aug; 61(8):506-9. PubMed ID: 199232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of herpes simplex virus isolated from patients with recurrent herpes keratitis exhibiting "treatment-resistance" to 5-iodo-2'-deoxyuridine.
    Hirano A; Yumura K; Kurimura T; Katsumoto T; Moriyama H; Manabe R
    Acta Virol; 1979 May; 23(3):226-30. PubMed ID: 41435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular penetration of (125I)IVDU, a radiolabeled analogue of bromovinyldeoxyuridine.
    Maudgal PC; Verbruggen AM; De Clercq E; Busson R; Bernaerts R; de Roo M; Ameye C; Missotten L
    Invest Ophthalmol Vis Sci; 1985 Jan; 26(1):45-9. PubMed ID: 3967955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of BVDU ((E)-5-(2-bromovinyl)-2'-deoxyuridine) in the treatment of experimental herpes simplex keratitis in rabbits.
    Maudgal PC; De Clercq E; Descamps J; Missotten L
    Bull Soc Belge Ophtalmol; 1979; 186():109-18. PubMed ID: 554711
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experiences with virostatic therapy of herpetic keratitis].
    Miceková M; Veselý L
    Cesk Oftalmol; 1971 Mar; 27(2):119-21. PubMed ID: 4324844
    [No Abstract]   [Full Text] [Related]  

  • 17. Idoxuridine ocular insert therapy. Use in treatment of experimental Herpes simplex keratitis.
    Pavan-Langston D; Langston RH; Geary PA
    Arch Ophthalmol; 1975 Dec; 93(12):1349-51. PubMed ID: 173270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ac2IDU, BVDU, and thymine arabinoside therapy in experimental herpes keratitis.
    Hettinger ME; Pavan-Langston D; Park NH; Albert DM; De Clercq E; Lin TS
    Arch Ophthalmol; 1981 Sep; 99(9):1618-21. PubMed ID: 7283815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic inactivation with proflavine: quantitative comparison with iodo-deoxyuridine.
    Varnell ED; Kaufman HE
    Infect Immun; 1973 Apr; 7(4):518-9. PubMed ID: 4128402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of topical corticosteroids on the susceptibility of immune animals to reinoculation with Herpes simplex.
    Easterbrook M; Wilkie J; Coleman V; Dawson CR
    Invest Ophthalmol; 1973 Mar; 12(3):181-4. PubMed ID: 4348132
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.